Recent Articles
Posted By: Michael C. Soulen, MD
Wed Apr 6th, 2016
As trainees, we only see a small part of the process of treating any individual patient, usually at the stage of administering locoregional therapy in interventional radiology. In this setting, it can be difficult to fully understand the role of IR within the larger picture of multidisciplinary care
Posted By: Michael C. Soulen, MD
Wed Feb 3rd, 2016
Whether you are a trainee or practicing interventional radiologist, IO University will provide you the oncologic education you need. Five years in the planning with a budget of more than $1 million, IO University is a global resource for IO on-line learning.
Posted By: Michael C. Soulen, MD
Wed Mar 6th, 2013
The IO Central Chemoembolization Discussion Group this week raised the issue of getting insurance approval for atypical tumors. Not surprisingly, the insurer in this case turned out to be Blue Cross, one of the worst carriers for Interventional Oncology procedures.
Posted By: Michael C. Soulen, MD
Mon Nov 12th, 2012
If there were level one evidence to support a particular practice, there wouldn’t be much of a debate! The popularity of this theme is a sign of the lack of clear cut best practice in what is a large and developing part of many interventional radiology practices.
Posted By: Michael C. Soulen, MD
Tue Aug 28th, 2012
One of my favorite patients died this month. I first met him in January, 2008 when he was diagnosed with liver cancer. He was a 60-year-old martial arts and music instructor, a seriously cool dude who always showed up in rimless sunglasses with his grey hair tied back in a neat queue.
At diagnosi